SCHEMBL2476900

SCHEMBL2476900

CC1=C([C@H]2CCC[C@@H](c3ncccc3C)N2)NCC=C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 5/20 0.34
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2473071 1.00 OPRL1 (0.34) OPRL1OPRM1
SCHEMBL2472143 0.84
SCHEMBL5574831 0.84
SCHEMBL2472847 0.84 OPRL1 (0.43) OPRL1OPRM1
SCHEMBL30586977 0.84 OPRL1 (0.43) OPRL1OPRM1
SCHEMBL2472323 0.84 OPRL1 (0.43) OPRL1OPRM1
SCHEMBL5575295 0.83
SCHEMBL4247676 0.83
SCHEMBL5574130 0.83
SCHEMBL2476894 0.75 OPRL1 (0.33) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374804-A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy Genzyme Corporation (US) 2011-10-12 EP disclosed
US-7550484-B2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy GENZYME CORPORATION (US) 2009-06-23 US disclosed
EP-1809613-A2 METHODS OF MAKING 2,6-DIARYL PIPERIDINE DERIVATIVES ANORMED INC. (CA) 2007-07-25 EP disclosed
WO-2006049764-A2 METHODS OF MAKING 2,6-DIARYL PIPERIDINE DERIVATIVES ANORMED INC. (CA) 2006-05-11 WO disclosed